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Alveolar type II (ATII) cells play a key role as part of the distal lung epithelium,
including in the innate immune response and as self-renewing progenitors to re-
place alveolar type I (ATI) cells during epithelial regeneration. Their secretion
of surfactant protein helps maintain homeostasis and exerts protective, antimi-
crobial properties. ATII cells remain difficult to study, partly due to inefficient
and expensive isolation methods, a propensity to differentiate into ATI cells,
and susceptibility to fibroblast contamination. Published methods of isolation
often require specialized technology, negatively impacting the development of
in vitro models of disease, including bovine tuberculosis. Presented here is a
simple and cost-effective method for generation of bovine primary ATII cells.
These cells exhibit an ATII phenotype in 2D and 3D culture and are conducive
to further study of the role of ATII cells in bovine respiratory diseases. C© 2019
by John Wiley & Sons, Inc.
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INTRODUCTION
The alveoli are specialized regions of the distal lung, with a morphology that is favorable
to efficient gaseous exchange. Two types of epithelial cell line the alveolus. Alveolar type
I (ATI) cells exhibit a broad, flattened morphology and cover around 95% of the alveolus
surface area, whereas alveolar type II (ATII) cells are cuboidal and line the remainder
of the alveolus (Fujino et al., 2011). ATI cells provide a gas exchange interface with the
underlying endothelium, whereas ATII cells serve as progenitors of ATI cells and also
play a critical role in maintaining the homeostasis of the alveolus (Driscoll et al., 1995;
Fehrenbach, 2001).
The ATII cell is the only epithelial cell of the lung that synthesizes and releases all
four surfactant proteins A, B, C, and D, with surfactant protein C being unique to the
ATII cell (Phelps & Floros, 1991). Studies utilizing ATII cells or cell lines derived
from them are vital to the elucidation of host-pathogen interactions, including diseases
falling under the One Health remit, such as tuberculosis, in the top ten causes of death
worldwide (WHO, 2017). The causative agent of bovine tuberculosis (BTB), Mycobac-
terium bovis, can cause progressive disease in most warm-blooded mammals, and the
WHO estimates that 3.1% of all human cases of tuberculosis are caused by BTB (WHO,
2017). New in vitro models of the alveolus are required to enable comparative stud-
ies between species and evaluate the role of ATII cell in the initial stages of BTB
pathogenesis.
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Evaluating the role of ATII cells in bovine pulmonary diseases such as BTB requires an
efficient method of isolating ATII cells. This article describes a simple ATII cell isolation
technique from cattle of less than 24 months. No specialized equipment is required (as
with flow cytometry or magnetic separation). The full protocol combines dissection,
mincing, and enzymatic digestion (see Basic Protocol 1), selective adherence (see Basic
Protocol 2), and gradient centrifugation (see Basic Protocol 3). This approach results in a
predominantly epithelial cell population (85-90%) that exhibits an ATII phenotype (Lee
et al., 2018) together with 10-15% fibroblasts. The latter may be removed for downstream
applications by cold trypsinization (see Basic Protocol 4).
STRATEGIC PLANNING
The success of isolating ATII cells using this method is dependent on robust logistics
being in place. If there are no animals available onsite, a working relationship with a
local slaughter facility is required. All solutions may be prepared a day in advance, with
the exception of the digestion solution, which contains temperature-sensitive enzymes
and should therefore be prepared on the day of use. It is also recommended that bovine
IgG–coated plates be prepared the day before use and stored at 2-8°C with the coating
solution in situ.
BASIC
PROTOCOL 1
DIGESTION OF DISTAL LUNG TISSUE TO GENERATE A MIXED
POPULATION OF CELLS
The initial step in the isolation process is the mincing of distal lung tissue and enzymatic
digestion to generate a mixed population of cells. Lungs may be supplied by a local
slaughter or fallen stock facility from cattle that are health-screened at the point of
slaughter by the attending veterinary surgeon. Animals showing signs of acute respiratory
distress or clinical signs such as coughing or excessive nasal discharge at this stage should
be excluded on the basis that cells from such animals represent an increased risk of cell
contamination (particularly fungal) for both isolated cells arising from this procedure
and other cells cultured in the facility. For consistency, approximately 100 g of tissue
is removed from the right distal lobe. An addition sample of right distal lobe tissue is
reserved for histological analysis by a veterinary pathologist to confirm the healthy status
of the tissue. Ear tag numbers may be noted for each animal used for disease surveillance
purposes.
The tissue is first minced and then washed to remove residual connective tissue, blood
cells, and vessels. This increases the purity of the isolated population, and the antibiotics
used reduce the likelihood of bacterial contamination. The minced tissue is then digested
in a mixture of enzymes optimized for bovine lung tissue. The recipe in this protocol is
adapted from Mao et al. (2015).
Materials
Right distal lung, acquired as part of a tracheal ‘pluck’, from cattle < 24 months old
Wash solutions A-C (see recipe)
Digestion solution (see recipe)
Neutralization solutions (see recipe)
10% (v/v) neutral buffered formalin (NBF, optional)
5% Virkon disinfectant solution
Adhesion solution (see recipe)
70% (v/v) industrial methylated spirits (for sterilizing tools)
Class II microbiological safety cabinet (MBSC)
UV lamp (recommended)Lee and
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Figure 1 Anatomy of the bovine lung. The distal (inferior) lung is taken for isolation of alveolar
type II cells (dashed line). Prior to digestion, it is first necessary to remove the outer (pleural)
membranes that completely surround the lung.
Sterile bag
Sterile carving knife
Dissection instruments: sterile scalpels, forceps, and scissors
15-cm sterile Petri dish
Sterile 50-ml graduated tubes
5-liter waste container with lid
Tube rocker or rotator
Matrix Filter Cell MicroSieve, 25-, 50-, and 100-μm pore size (Fisher)
Large funnel (>20 cm diameter)
Sterile glass beakers (one for each filtration step)
NOTE: All solutions should be stored at 2-8°C until use. All centrifugation steps are
performed at 4°C. Enzymatic digestion should be performed at 37°C.
Dissect and wash lung tissue
1. On the day of isolation, assemble wash solutions A-C and add DNase I to neutral-
ization and adhesion solutions. Prepare fresh digestion solution. Cool all solutions
to 2-8°C.
2. Set up dissection area in an MBSC. For additional biosecurity, switch on a UV light,
if available.
3. Retrieve lungs from point of slaughter, ideally in a sterile bag containing solution
A. Remove the distal third of the right lobe (the inferior lobe; Fig. 1) using a sterile
carving knife. Transport to the MBSC in solution A (1 liter).
At this point, a veterinary pathologist may be employed to perform gross examination of
the lungs received to ensure the absence of clinical signs of respiratory disease in the
animal.
Lee and
Chambers
3 of 14
Current Protocols in Toxicology
4. In the MBSC, use a scalpel to remove 1 cm3 tissue for histological analysis by a
veterinary pathologist, if required. Place the sample into a suitable vessel containing
10% NBF.
5. Add 5 ml wash solution B to a 15-cm sterile Petri dish to keep the dissected tissue
moist. Remove the pleural membranes using a scalpel, then take 1-cm3 pieces of
lung tissue and use scissors and a scalpel to mince them to1-mm3 pieces. Transfer
pieces to 50-ml sterile tubes, filling each to the 10-ml mark with minced tissue.
It is recommended to use both the dish and the inverted lid, adding solution B to each.
A minimum of eight 50-ml tubes is typically needed for 100 g tissue.
6. Fill each tube to the 40-ml mark with wash solution C. Shake vigorously for 1 min
and then discard the supernatant into 5% Virkon disinfectant solution in a 5-liter
waste container. Repeat until the supernatant is clear (at least eight washes).
If the tissue floats, it may be more practical to aspirate the supernatant from below with
a serological pipette.
Digest and filter tissue
7. Add 20 ml digestion solution to each 50-ml tube and agitate by rocking or rotating
at 37°C for 60 min.
8. Neutralize enzymatic activity by adding 20 ml neutralization solution and rocking
briefly to mix.
9. Filter pieces sequentially through a 100-, 50-, and 25-μm filter membrane by over-
laying the membrane onto a funnel. Collect the crude cell suspension in a sterile
beaker and divide between 50-ml tubes.
10. Spin at 300 × g for 10 min at 4°C.
11. Resuspend in 40 ml adhesion solution and proceed immediately to Basic
Protocol 2.
BASIC
PROTOCOL 2
REMOVAL OF MACROPHAGES AND FIBROBLASTS BY SELECTIVE
ADHERENCE
This technique is based on the panning method published by Wysocki and Sato (1978)
as a method of fractionating T and B lymphocytes and applied by Dobbs, Gonzalez, and
Williams (1986) to isolation of ATII cells from rat lung. The method is based upon the
ability of antibody molecules to simultaneously adhere to polystyrene surfaces and bind
antigen. Here it is used to also reduce the number of contaminating fibroblasts, which
have previously been reported to show a greater affinity for bacterial grade polystyrene
(Ehrhardt, Kim, & Lehr, 2005). Plates may be coated overnight at 2-8°C or for 40 min at
room temperature under sterile conditions.
Materials
Gamma globulin (IgG) from bovine serum (Sigma)
0.05 M Tris buffer, pH 9.5 (Fisher), filter sterilized (0.2-μm)
Centrifugation solution (see recipe)
Wash solution C (see recipe)
Digested cell suspension in adhesion solution (see Basic Protocol 1)
150 × 15–mm bacterial grade polystyrene Petri dishes
37°C incubator
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1. In the MBSC, add IgG from bovine serum to Tris buffer at a final concentration of
5 μg/ml. Add DNase I to centrifugation solution.
2. Overlay six Petri dishes with 10 ml IgG solution and swirl to distribute evenly. Let
sit at room temperature for 40 min or overnight at 2-8°C.
Coating overnight at 2-8°C is recommended for ease of logistics, but both methods may
be used with equal success.
3. Remove IgG solution and gently rinse dishes twice with wash solution C.
4. Pour 10 ml cell suspension onto each plate and swirl to ensure coverage. Incubate
at 37°C for 1 hr, rocking mid-way through the incubation to redistribute cells.
A maximum of 9 × 107 cells should be added to each 150-mm Petri dish (9 × 106
cells/ml). If the cell count exceeds this amount, the volume of adhesion solution used
to resuspend the cell pellet should be adjusted accordingly and more IgG-coated Petri
dishes used.
5. Collect supernatant containing non-adherent cells, consolidating it in 50-ml tubes.
6. Centrifuge at 300 × g for 10 min at 4°C. Resuspend in 8 ml centrifugation solution,
combining all pellets into a single suspension, and proceed immediately to Basic
Protocol 3.
DNase I should be added to centrifugation solution fresh before each use.
BASIC
PROTOCOL 3
GENERATION OF ENRICHED ATII FRACTION BY PERCOLL GRADIENT
CENTRIFUGATION
The Percoll reagent was first formulated by Pertoft, Laurent, La˚a˚s, and Ka˚gedal (1978).
When poured as a density gradient, it separates cells or particles using the principle
of isopycnic separation. During centrifugation, particles or cells will settle where their
density has reached equilibrium with the density of the surrounding medium. Density
gradients of this nature have been successfully used numerous times in previous studies
where ATII cells have been isolated (Gonzalez & Dobbs, 2013; Mao et al., 2015; also
reviewed by Dobbs, 1990). The use of a three-phase Percoll gradient (4%, 10%, and 30%)
results in an enriched band of ATII cells at the interface of the 10% and 30% phases.
This is removed and resuspended in small airway growth medium to dilute the Percoll
and allow pelleting by centrifugation. Finally, the cell pellet is resuspended and used to
establish cultures and determine phenotype by immunofluorescent staining of ATII cell
markers (Lee et al., 2018).
Materials
Light and heavy Percoll gradient solutions (see recipe)
Phenol red
Enriched cell suspension in 4% Percoll (see Basic Protocol 2)
Centrifugation solution (see recipe)
Wash solution C (see recipe)
Small airway growth medium (SAGM)
Freezing medium (see recipe)
4% (w/v) paraformaldehyde (Sigma)
DPBS (Fisher, 12037539)
0.1% Triton X-100 (Sigma) in DPBS
5% normal serum in DPBS
Primary antibodies:
Rabbit anti-prosurfactant protein C (proSP-C) (ab3786, Millipore)
Mouse cytokeratin 18 (CK18) (sc32329, Santa Cruz Biotechnology) Lee andChambers
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Mouse anti-CD74, FITC conjugated (CD74-FITC) (sc47742, Santa Cruz
Biotechnology)
Appropriate fluorophore-labeled secondary antibodies
Aqueous mounting medium (optional)
15- and 50-ml centrifuge tubes
Tube stand
10-ml serological pipettes
Benchtop centrifuge with swinging-bucket rotor (e.g., Eppendorf 5810R)
1000-μl pipette
Trypan blue
Automated cell counter or hemocytometer
T25 and T75 tissue culture flasks
37°C incubator
Cryovials (Nunc)
Chambered coverglass (Nunc)
Inverted microscope
Microscope slides (optional)
Pour Percoll gradients
1. Prepare desired amounts of light and heavy Percoll gradient solutions (10% and
30%). Add two drops of phenol red to the heavy solution.
2. Place eight 15-ml centrifuge tubes on a stand. Without touching the sides of the
tubes (i.e., filling from the bottom up), add 6 ml heavy solution to each tube. Avoid
introducing bubbles.
3. Gently overlay 8 ml light solution onto the heavy solution in the first tube (Fig. 2A)
as follows:
a. Aspirate a little >8 ml of light solution into a 10-ml serological pipette.
b. Holding the end of the pipette over a waste vessel, remove the pipette filler and
quickly seal the top of the pipette using the thumb (Fig. 2B). Then, release the
thumb slightly and allow the light solution to drain by gravity until the 8-ml mark
is reached.
c. Move the pipette to the gradient tube. Hold the tube at a 30° angle and very
slightly move the thumb to release a little of the solution (a drop or so), allowing
the drop to run down the inside of the tube.
Figure 2 Preparation of a Percoll gradient. The first stage involves the bottom-up pouring of the
heavy (30%) fraction by holding the serological pipette tip at the base of the tube and raising it
as the liquid is dispensed. This avoids introduction of bubbles. The tube is then inclined at 30° for
the overlaying of the light (10%) fraction (A), which is executed by extremely gentle release of the
thumb’s seal at the top of the pipette (B). Upon completion of Percoll gradient centrifugation, there
should be a milky white band at the interface of the 10% and 30% fractions, which will contain a
cell population enriched for ATII.
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d. Repeat until multiple drops have joined to create the 10-30% Percoll interface.
Continue to overlay the light gradient solution in this way until all 8 ml have been
applied.
Allowing too much solution to dispense will disturb the interface. The phenol red in the
heavy fraction allows easy visualization of the interface. A clear line should be seen. If
a clear line cannot be observed, the gradient should be discarded.
4. Repeat with remaining tubes.
It is best to prepare Percoll gradients immediately before use, during the adherence phase
of the isolation protocol.
Perform gradient centrifugation
5. Gently overlay 1 ml cell suspension on the top of each tube, so that a clear line forms
at the interface between the 4% uppermost layer and the 10% fraction. Keep tubes
upright at this stage and avoid knocking them.
6. Centrifuge at 400 × g for 20 min at 4°C using a swinging-bucket rotor. Set acceler-
ation on the lowest setting and the brake off.
Braking should be off because it is important not to disturb the gradient. If this function
is not available, switch the centrifuge off manually and allow it to slow naturally to a
halt before switching it back on to retrieve samples.
Unless the gradient has been disturbed during pouring or centrifugation, a milky white
band forms at the interface between the 10% and 30% phases and contains an enriched
layer of ATII cells.
7. Remove the entire gradient by careful pipetting, 1 ml at a time, working from the top
down. Pool fractions from all eight gradients into 4%, 10%, interface (ATII cells),
30%, and pellet fractions in 50-ml tubes. To confirm successful enrichment, keep
all fractions.
Removal of the interface region should include 1 ml on either side of the white
band of cells. Removal of the band is most effective when slowly moving the pipette
tip around the perimeter of the band while aspirating. To ensure no cells are lost,
all fractions should be kept until ATII cells have been identified by morphology and
biomarkers.
8. Dilute each fraction in wash solution C to lower the Percoll concentration to below
10%.
This is necessary to enable pelleting without generating excess shear forces.
9. Spin each fraction at 300 × g for 10 min at room temperature. Perform a viable cell
count by trypan blue exclusion and resuspend each pellet to no less than 300,000
cells/ml in SAGM. Proceed simultaneously to culturing and phenotyping by im-
munostaining.
The expected yield is 6 × 106 cells.
Culture cells
10. Seed 2.5 × 105 or 7.5 × 105 isolated cells into T25 or T75 tissue culture flasks,
respectively, and grow in a 37°C. Monitor for fungal or bacterial growth under a
light microscope. To maintain high density, passage ATII cells up to 1:4 when they
reach 75-80% confluence. At time of passage, freeze stocks in freezing medium at
a concentration of 1,000,000 cells/ml.
Typically, ATII primary cells may be cultured in SAGM for 10-12 passages before senes-
cence. Splits greater than 1:4 are not recommended, as they will result in growth arrest. Lee and
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ATII cells freeze well, maintaining a viability of greater than 90% upon thawing. One
vial (containing 1 million cells/ml) can be thawed, diluted directly into 7 ml SAGM, and
plated onto a T25 tissue culture flask using routine culture conditions.
ATII cells readily differentiate into ATI cells when cultured submerged on 2D plastic.
This differentiation appears to be reversible, as previously reported by Wang et al. (2007)
and observed in our own studies. To maintain the ATII phenotype, it is recommended that
ATII cells be cultured at an air-liquid interface or as 3D cultures, as described by (Lee
et al., 2013).
Confirm ATII phenotype
11. Seed 3000 freshly isolated cells (or 1-2 days culture, if seeding onto uncoated
surfaces) onto a chambered coverglass and grow overnight.
12. Fix 1-day-old cultures for 30 min in 4% paraformaldehyde, then permeabilize for
10 min in 0.1% Triton X-100 in DPBS.
13. Block nonspecific staining with 5% normal serum/95% DPBS for 30 min.
14. Incubate with primary antibodies diluted 1:100 in blocking buffer overnight at 4°C.
anti-prosurfactant protein C
anti-cytokeratin 18
FITC-conjugated anti-CD74
15. Wash cells 3 × 5 min with DPBS.
16. Incubate with fluorophore-labeled secondary antibody for 1 hr at room temperature.
Suitable fluorophores include Alexa Fluor 488 and 594.
17. Wash as before.
18. Visualize directly using an inverted microscope or mount in aqueous medium on a
microscope slide for visualization at a later time.
Morphological features characteristic of ATII cells include lamellar inclusion bodies.
These may be demonstrated by modified Papanicolaou staining as outlined in detail
in Dobbs (1990). Like many other epithelial cells, ATII cells exhibit a cobblestone
morphology at confluence. The cuboidal shape is observed only in cross-sections.
BASIC
PROTOCOL 4
REMOVAL OF CONTAMINATING FIBROBLASTS FROM EPITHELIAL
CULTURES
Fibroblast contamination is a common problem in the culture of primary epithelial
cells isolated from fresh tissue. Two previously published methods may be used to
reduce fibroblast contamination (Pal & Grover, 1983). The first exploits differential
rates of detachment in the presence of cold trypsin. This enriches the culture for ATII
cells considerably; however, epithelial cells also detach, thus depleting cell numbers
considerably. Despite the removal of many epithelial cells in addition to fibroblasts, this
method has merits for experiments requiring ultrapure cultures.
If a higher viable cell count is required, a relatively simple alternative can be employed.
This method is based on relative susceptibility to treatment with HBSS. It results in the
removal of fibroblasts and >90% viability of the remaining epithelial cells.
The most distinguishable feature of fibroblasts is their spindle-like morphology. Fibrob-
lasts are much longer than they are wide and produce a greater contrast against the tissue
culture surface when visualized under a phase-contrast microscope (Fig. 3A). Epithelial
cells exhibit a cobblestone morphology (Fig. 3B) and do not produce such a striking
contrast. This makes contaminating fibroblasts easy to find in epithelial cell cultures.
Lee and
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Figure 3 Fibroblast removal from ATII cultures. Fibroblasts are notable for their elongated
spindle-like morphology (A, arrows). Following their removal, ATII cells exhibit a cobblestone
morphology when allowed to grow to confluence (B).
Materials
Cultured ATII cells (see Basic Protocol 3)
0.25% trypsin
DMEM/F12/FBS: 1:1 (v/v) DMEM/F12 with glucose, glutamine, phenol red,
HEPES, and sodium pyruvate (Fisher) containing 10% FBS (heat inactivated;
Fisher)
DPBS, Ca2+/Mg2+ free (Fisher)
Small airway growth medium Bulletkit (Lonza, CC-3118)
Hanks’ balanced salt solution (HBSS, Fisher)
Phase-contrast microscope
Cold Trypsin Treatment
1a. Remove cultures from incubator. Add ice-cold 0.25% trypsin to cultures (1.5 ml for
a T25 flask or 3 ml for a T75 flask) and leave in the MBSC for 2 min.
2a. Remove supernatant containing contaminating fibroblasts (and some epithelial cells)
and discard.
3a. Immediately wash remaining adhered cells with DMEM/F12/FBS to neutralize any
remaining trypsin.
4a. Wash adhered cells with DPBS and feed with SAGM.
5a. Check cells under a microscope for density. If cells are <20% confluent, add fresh
warm 0.25% trypsin, neutralize as per routine passage procedure, and consolidate
cultures in tissue culture flasks at a minimum density of 5000 cells/cm2.
HBSS Treatment
1b. Remove cultures from incubator and wash twice with DPBS.
2b. Add HBSS (5 ml for a T25 flask or 10 ml for a T75 flask) and return flasks to
incubator. Check cultures every 10-15 min under a microscope.
Detached fibroblasts are observed within 15 min of incubation in HBSS. The previous
literature reports incubating for 2-3 hr. The majority of fibroblasts should be floating
after 30 min incubation.
3b. When no attached fibroblasts are observed in the culture, remove supernatant con-
taining contaminating fibroblasts and discard. Lee and
Chambers
9 of 14
Current Protocols in Toxicology
4b. Wash cultures briefly with DPBS and feed as usual with SAGM. If density is below
20%, passage cells as described in step 5a.
REAGENTS AND SOLUTIONS
Use Milli-Q-purified water or equivalent in all recipes and protocol steps.
Adhesion solution
100 ml 1:1 (v/v) DMEM/Ham’s F12 (Fisher)
100 ml small airway growth medium (SAGM; Lonza, CC-3118)
10 ml FBS (heat inactivated; Fisher)
Filter sterilize (0.2 μm)
Store up to 1 month at 2-8°C
Before use, add 2% (w/v) DNase I (2000 KU/mgP; Sigma, D5025)
Centrifugation solution
10 ml wash solution C (see recipe)
4% (v/v) Percoll (Sigma)
4% (v/v) FBS (heat inactivated; Fisher)
Store up to 1 month at 2-8°C
Before use, add 0.01% (w/v) DNase I (2000 KU/mgP; Sigma, D5025)
Digestion solution
100 ml DPBS
1 ml 100× pen/strep (10,000 U/ml final; Fisher, 11548876)
0.008% (w/v) porcine pancreas elastase (Fisher, 15484279)
0.2% (w/v) collagenase (Fisher, 15434789)
0.005% (w/v) DNase I (2000 KU/mgP; Sigma, D5025)
0.05% (w/v) trypsin (Fisher, 11560626)
Prepare under sterile conditions
Filter sterilize (0.2 μm)
Store at 2-8°C and use within 24 hr
Freezing medium
50% 1:1 (v/v) DMEM/Ham’s F12 (Fisher)
40% FBS (heat inactivated; Fisher)
10% DMSO (Sigma)
Store up to 1 month at 2-8°C
Neutralization solution
100 ml 1:1 (v/v) DMEM/Ham’s F12 (Fisher)
25% (v/v) FBS (heat inactivated; Fisher)
Filter sterilize (0.2 μm)
Store up to 1 month at 2-8°C
Before use, add 0.01% (w/v) DNase I (2000 KU/mgP; Sigma, D5025)
Percoll gradient solutions, light (10%) and heavy (30%)
50 ml wash solution C (see recipe)
10% or 30% (v/v) Percoll (Sigma)
Store up to 1 month at 2-8°C
Wash solution A
5 liters PBS (Oxoid tablets, Fisher, BR0014G)
50 ml 100× pen/strep (10,000 U/ml; Fisher, 11548876)
Filter sterilize (0.2 μm)
Lee and
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Store up to 1 month at 2-8°C
Compared to wash solution C, this solution uses PBS tablets to reduce cost during the
dissection. However, DPBS can also be used.
Wash solution B
500 ml DPBS (Fisher, 12037539)
5 ml 500 mM EDTA (Fisher, 10030140)
5 ml 100× pen/strep (10,000 U/ml; Fisher, 11548876)
Filter sterilize (0.2 μm)
Store up to 1 month at 2-8°C
Wash solution C
1 liter DPBS (Fisher, 12037539)
10 ml 100× pen/strep (10,000 U/ml; Fisher, 11548876)
Filter sterilize (0.2 μm)
Store up to 1 month at 2-8°C
COMMENTARY
Background Information
The study of early host-pathogen inter-
actions between infectious agents and ATII
cells is crucial to advancing our understand-
ing of the pathogenesis of infectious respira-
tory disease in cattle, including bovine tuber-
culosis (BTB). Furthermore, the development
of successful disease prevention and treatment
strategies requires reliable in vitro models of
the bovine alveolus, beginning with the con-
sistent and efficient isolation of ATII cells.
The methods outlined here are simple, repro-
ducible, and cost-effective. They have wide
implications, not least the possibility of trans-
fer to other species and application by in-
stitutes lacking animal housing facilities or
easy access to sophisticated equipment. In our
hands, previously reported methods of isolat-
ing ATII cells, such as flow-activated cell sort-
ing (FACS; Gereke et al., 2012) and magnetic
bead isolation (Chen, Chen, Narasaraju, Jin,
& Liu, 2004), have been unsuccessful, most
likely due to the detrimental effect of the diges-
tion process, which destroyed surface mark-
ers, a phenomenon reported previously (Gedye
et al., 2014).
Critical Parameters and
Troubleshooting
These protocols are particularly suited to
institutes without live animal facilities and
those with easy access to slaughter facilities,
such as abattoirs and fallen stock services.
The ATII cell is reported to be the stem
cell of the alveolus (Barkauskas et al., 2013),
acting as the progenitor cell of the differen-
tiated ATI cell. A key finding has been the
senescence of ATII cells at passage 10-12.
Replicative senescence was first reported by
Hayflick (1965), describing the processes by
which cultured primary human cells undergo
only a limited number of passages before los-
ing their proliferative capacity. For this rea-
son, studies using primary ATII cells isolated
from adult bovine lungs should only be per-
formed on cells up to passage 9. Furthermore,
as senescent cells can be assumed to be more
prevalent with age, younger donor animals
should give higher yields of ATII cells (Kat-
sara et al., 2011; Zaim, Karaman, Cetin, &
Isik, 2012).
Another consideration is the use of basic
techniques to isolate ATII cells. The reason
for this is the detrimental effect of enzymatic
digestion upon cell surface markers. The bind-
ing of debris to the ATII marker CD74 in both
FACS and magnetic bead isolation has been re-
ported (Lee et al., 2018). Changing the recipe
of the digestion mix is not advised, due to the
high content of collagen previously reported in
bovine lungs (Cohen, Zelikoff, & Schlesinger,
2000) and the improved yield as a result of the
inclusion of trypsin (Dobbs et al., 1986). How-
ever, there is merit to the theory that refine-
ment of the isolation technique by downstream
(passage 1 or later) magnetic bead or FACS
methods will remove contaminating cells and
improve purity of the culture.
Particular care should be taken when pour-
ing Percoll gradients. When overlaying the
10% solution onto the 30% solution, there is
a risk of the gradients mixing at the interface.
This will affect the quality of the gradient and
cause cells to form a smear against the side of
the tube rather than a distinct band at the inter-
face. It is recommended that one practice the
Lee and
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technique prior to the day of isolation and also
pour more gradients than required in order to
afford the luxury of choosing the most distinct
layers.
Guidelines on the characterization of ATII
cells isolated from bovine lungs can be found
in Lee et al. (2018). Studying the expres-
sion of ATII biomarkers is useful for ini-
tial analysis; however, differentiation under
two-dimensional submerged culture condi-
tions will affect the number of ATII cells ob-
served, since these conditions accelerate the
differentiation of ATII into ATI cells. This dif-
ferentiation is in part reversible in vitro by
culturing the ATII cells in Matrigel (100%;
BD Biosciences) or on Matrigel-coated per-
meable membranes as polarized monolay-
ers. Under these conditions, expression of
the ATII markers CD74 and proSP-C is re-
tained (Lee et al., 2018; Wang et al., 2007),
along with the formation of lamellar inclusion
bodies, the hallmark identifier of ATII cells in
vitro and in vivo (Dobbs, Pian, Maglio, Du-
mars, & Allen, 1997; Lee et al., 2018; Mao
et al., 2015). Thus, if the ATII phenotype is
lost during routine culture of cell stocks, a sub-
culture can be grown as outlined above to as-
sess phenotype. ATII cells can also be cultured
as submerged 2D monolayers prior to studies
performed on Transwell inserts. Although the
ATII phenotype is lost in the former, it can be
resurrected in the latter, as evidenced by im-
munofluorescence and transmission electron
microscopy (Lee et al., 2018). The reversibil-
ity of differentiation is not a new discovery. It
has been well documented that ATII cells lose
such morphological characteristics as lamellar
inclusion bodies and microvilli over a period
of 1-7 days when grown on uncoated tissue
culture plastic (Dobbs, 1990), but subsequent
culture of seemingly differentiated cells results
in reversal or de-differentiation, restoring the
expression of ATII markers such as surfactant
proteins A and C (SP-A and SP-C) (Dobbs
et al., 1997; Wang et al., 2007).
Fungal contamination is an occupa-
tional hazard when isolating cells from or-
gans exposed to the external environment.
Amphotericin B may be effective in control-
ling fungal infection; however, it should be
borne in mind that epithelial cells are also af-
fected. If the source of tissue results in re-
peated failures due to fungal infection, it is
recommended to plate cells in six-well plates
and monitor cultures twice daily under a light
microscope for signs of infection (fibrous
mycelium). Wells that are infected may be
treated with amphotericin B at a high dose
by replacing the medium with amphotericin B
stock solution (250 μg/ml) and leaving it in
situ for about one hour. This effectively sacri-
fices that well, but neighboring wells are un-
affected by this high concentration.
In summary, we offer the following sug-
gestions: (1) freeze stocks to maximize the
number of cells generated by one isolation,
(2) restrict studies to cells cultured up to pas-
sage 9, (3) perform fibroblast removal on cells
to be used in studies requiring a pure culture,
and (4) be vigilant about infection, culturing
in the presence of antibiotics for at least one
week after isolation.
Anticipated Results
Cells isolated using these procedures
should form a cobblestone morphology in-
dicative of epithelial cells and exhibit markers
characteristic of the ATII phenotype, including
proSP-C, CD74, cytokeratin 18, and epithelial
cell adhesion molecule (EpCAM). Differentia-
tion of ATII cells into ATI cells may be studied
by following the expression of the ATI marker
aquaporin 5 (Aqp5). The increase of AQP5
mRNA expression is concomitant with a corre-
sponding decrease in SFTPC in submerged 2D
cultures over time, a key indicator of the dy-
namic and inverse relationship between these
two cell markers (Kondo, Miyoshi, Sakiyama,
Tangoku, & Noma, 2015; Lee et al., 2018).
Time Considerations
Half a day should be set aside to prepare so-
lutions in advance, with the exception of those
stated above. When performed by experienced
personnel, the isolation protocol takes 7 hr
from receipt of lungs to seeding of isolated
cells. The time taken to transport the lungs
from the point of slaughter to the laboratory
should also be taken into account. A class II
microbiological safety cabinet is necessary for
the dissection procedure to maintain sterility.
Collection of lungs is dependent upon the
distance of the slaughter facility from the lab-
oratory. It can take up to 7 days for isolated
cells to reach confluence, although this has
been achieved in as little as 4 days.
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This article outlines the isolation protocol in brief
and includes data appertaining to the initial
characterization of ATII cells. This includes mor-
phology by light microscopy, mRNA expression,
and phenotype by immunofluorescence.
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